Hints and tips:
Related Special Reports
...Merck’s Covid-19 antiviral pill failed to show it can lower the risks of hospitalisation and death among adults at higher risk from the disease, according to the results of a pivotal clinical trial in the...
...Dean Li, president of Merck’s research laboratories, praised the UK’s scientific talent and expertise, hoping that the investment in King’s Cross will help researchers at MSD, known as Merck in the US, work...
...But future demand would suffer unless Merck was able to provide better clinical data....
...And what are the incentives of Merck Mercuriadis after the transaction?...
...A person familiar with the process said Merck “understood there was no hope . . . [Lagevrio] is a bit burnt”....
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
...He said Merck’s claim that the reforms were an “extortion” was accurate....
...Molnupiravir, marketed by Merck and co-developed with US biotech group Ridgeback Biotherapeutics, works by inducing small mutations in the virus itself....
...When Ken Frazier, another law school friend, was CEO of Merck and facing criticism for refusing to cut research budgets, Ogunlesi reassured him he was doing the right thing....
...Merck is either optimistic or desperate if it is willing to pay $5bn more than Prometheus’ valuation three days ago. But it has the funds....
...Under the terms of the transaction Merck is acquiring Prometheus through a subsidiary....
...Investors have also questioned the relationship with Blackstone, which both co-owns the management company for Hipgnosis as well as a rival fund that is still buying song rights....
...“We are encouraged by these findings from Panoramic,” said Merck, which is known as MSD outside North America....
...Weber is a paid consultant for Merck and Moderna....
...MSD, known as Merck in the US, expects competition for its Keytruda cancer treatment from late 2028. Sales of Eliquis, a small molecule pill, are expected to top $13bn in 2025....
...“When appropriate, Merck seek to protect its additional innovation,” he added. Merck said it continued to point to late 2028 as the most likely timeframe for biosimilar entry into the market....
...Founded by Merck Mercuriadis, Hipgnosis became a ferocious buyer of music rights, building a multibillion-dollar portfolio that includes artists like Neil Young, the Red Hot Chili Peppers and Shakira....
...TSMC said it “maintains a strong and close partnership with its suppliers, which includes open communication channels and strict co-operation on technology confidentiality management”....
...His efforts included a conversation with an unnamed “board member I knew at BI” and approaches to KKR co-founder Henry Kravis, its co-CEO Joseph Bae and Axel Springer’s Döpfner....
...Chief financial officer Caroline Litchfield said the company operates with the highest “ethics and integrity in absolutely everything we do” and is continuing to co-operate with the Senate finance committee...
...SeaGen lacks a permanent chief executive after co-founder Clay Siegall stepped down in May, so Merck may be tempted to push ahead....
...& Co Q1, Microsoft Q3, Nestlé Q1 sales figures, Northrop Grumman Q1, Persimmon AGM and trading update, Porsche Q1, Royal Caribbean Cruises Q1, Sainsbury’s FY, Schroders AGM and Q1 update, Snap Q1, Southwest...
...Merck’s Keytruda now tackles 18 tumour types and is set to be the world’s top-selling medicine next year, according to Evaluate Vantage....
...Merck & Co is in talks to buy the cancer biotechnology company SeaGen for about $40bn, according to two people familiar with the matter....
...FY, Brunswick Q4, BT Group Q3 trading update, Coursera Q4, Dassault Systèmes Q4, Icelandair Q4, ING Q4, International Paper Q4, Glencore Q4 production report, Hartford Financial Services Q4, Konami Q3, Merck...
International Edition